Koen Andries
From Wikipedia, the free encyclopedia
Koen Andries is a Belgian scientist working at Janssen Pharmaceutica and professor at the University of Antwerp. In 2005 he and his team published a discovery about a new di-Aryl-Quinoline-based drug (R207910) which promises a shorter and simpler treatment for Tuberculosis (TB)[1].
[edit] References
- ^ Andries K, Verhasselt P, Guillemont J, et al. (2005), A diarylquinoline drug active on the ATP-synthase of Mycobacterium tuberculosis, Science 307 (5707): 223–27
[edit] Source
- Cohen, MEDICINE: New TB Drug Promises Shorter, Simpler Treatment, Science 10 December 2004: 1872
- World: New Drugs Show Promise In Fight Against Tuberculosis
- New tuberculosis antibiotic may shorten treatment time, fight drug-resistant strains
[edit] External links
- Koen Andries (University of Antwerp)
This Belgian biographical article is a stub. You can help Wikipedia by expanding it.
